Melissa Loh

United States (US)
Board Member

Biographical Info
Dr. Melissa (Kah Poh) Loh is a geriatric oncologist with board certification in internal medicine; hematology, oncology, and geriatrics at the University of Rochester Medical Center, James P. Wilmot Cancer Institute, United States. Clinically, Dr. Loh specializes in caring for older adults with hematologic malignancies. She leads the geriatric hematology program at her institution. Dr. Loh’s long-term goal is to become an independent clinical investigator developing and implementing behavioral interventions, utilizing mobile health technologies, to improve outcomes for older adults with hematologic malignancies. Dr. Loh is also interested in studying mechanisms by which these interventions improve cancer-and treatment-related toxicities (such as decline in physical function). Dr. Loh other research interests include: 1) Prognostic understanding of older patients and their caregivers and 2) Treatment decision-making among older patients with acute myeloid leukemia. Dr. Loh is supported by the National Cancer Institute (NCI) K99/R00 and the Wilmot Cancer Institute (WCI) Research Fellowship Award. Dr. Loh has received over 40 research and scholarship awards, published over 90 manuscripts, and was the first or co-author on more than 110 oral and poster presentations. Dr. Loh is the Chair of the Young SIOG Interest Group (2020-2022, Co-Chair for 2017-2020) and Co-Chair of the American Geriatrics Society Cancer and Aging Special Interest Group (2019-2021). Dr. Loh also serves on the American Society of Hematology Committee on Education Affairs (2020-2023), Cancer and Aging Research Group Junior Investigator Board (2019-present), and American Society of Clinical Oncology Annual Meeting Education Committee for Geriatric Oncology (2019-2022, Chair for 2020-2021).